Jan Basile to Calcium Channel Blockers
This is a "connection" page, showing publications Jan Basile has written about Calcium Channel Blockers.
Connection Strength
0.872
-
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time. South Med J. 2007 Apr; 100(4):343-4.
Score: 0.272
-
The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens (Greenwich). 2004 Nov; 6(11):621-29; quiz 630-1.
Score: 0.230
-
Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):1-4.
Score: 0.088
-
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008 Oct; 10(10):751-60.
Score: 0.075
-
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
Score: 0.065
-
The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy. J Hum Hypertens. 2006 Mar; 20(3):169-75.
Score: 0.063
-
Halting the progression of heart failure: finding the optimal combination therapy. Cleve Clin J Med. 2002 Feb; 69(2):104-5, 109-10, 112.
Score: 0.048
-
Combination therapy in hypertension. J Am Soc Hypertens. 2010 Jan-Feb; 4(1):42-50.
Score: 0.021
-
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
Score: 0.011